SCHEMBL4829751

SCHEMBL4829751

Cc1noc([C@H](N)Cc2cccc(-c3ccc(F)c(Cl)c3)c2)n1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
DPP4 P27487 2/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
GRIN2B Q13224 1/20 0.35
PNMT P11086 1/20 0.35
MDM2 Q00987 1/20 0.34
CNR2 P34972 5/20 0.34
CNR1 P21554 3/20 0.34
ALDH1A1 P00352 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
AKT1 P31749 1/20 0.34
NISCH Q9Y2I1 1/20 0.33
PARP1 P09874 1/20 0.33
MET P08581 1/20 0.33
CACNA1B Q00975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4829583 0.99 TP53 (0.37) TP53MAPTDPP4ADORA2AADORA1
Hydrochloric Acid SCHEMBL4829588 0.99 TP53 (0.37) TP53MAPTDPP4ADORA2AADORA1
SCHEMBL4827765 0.90 DPP4 (0.38) DPP4GRIN2BALDH1A1AKT1NISCH
SCHEMBL3996630 0.90 DPP4 (0.38) DPP4GRIN2BALDH1A1AKT1NISCH
Hydrochloric Acid SCHEMBL4831560 0.89 DPP4 (0.37) DPP4GRIN2BALDH1A1AKT1NISCH
Hydrochloric Acid SCHEMBL4831555 0.89 DPP4 (0.37) DPP4GRIN2BALDH1A1AKT1NISCH
SCHEMBL4823412 0.82 TP53 (0.48) TP53MAPTPNMT
SCHEMBL4831799 0.82 DPP4 (0.40) TP53MAPTDPP4ADORA2AADORA1
Hydrochloric Acid SCHEMBL4829811 0.81 DPP4 (0.39) TP53MAPTDPP4ADORA2AADORA1
Hydrochloric Acid SCHEMBL4829817 0.81 DPP4 (0.39) TP53MAPTDPP4ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459472-B2 Aryl and heteroaryl compounds, compositions, and methods of use TRANSTECH PHARMA, INC. (US) 2008-12-02 US disclosed
US-20050059713-A1 Aryl and heteroaryl compounds, compositions, and methods of use VTVX HOLDINGS I LLC 2005-03-17 US disclosed
WO-2005014534-A1 ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE TRANSTECH PHARMA, INC. (US) 2005-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059713-A1 Aryl and heteroaryl compounds, compositions, and methods of use CYP2F1, CYP3A43, PNPO TP53 1053/4885MAPT 3605/4885DPP4 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.